Details on high frequency blood collection, data analysis, available material and patient characteristics in BIOMArCS

Details on high frequency blood collection, data analysis, available material and patient characteristics in BIOMArCS

The Biomarker Study to Identify the Acute Risk of a Coronary Syndrome (BIOMArCS) is a prospective, observational study that has been designed to study the evolution of blood biomarkers in post-acute coronary syndrome (ACS) patients. In our recently published study “Temporal evolution of Myeloperoxid...

Full description

Bibliographic Details
Main Authors:	Eric Boersma, Maxime M. Vroegindewey, Victor J. van den Berg, Folkert W. Asselbergs, Pim van der Harst, Bas Kietselaer, Timo Lenderink, Anton J. Oude Ophuis, Victor A.W.M. Umans, Robbert J. de Winter, Rohit M. Oemrawsingh, K. Martijn Akkerhuis
Format:	Article
Language:	English
Published:	Elsevier 2019-12-01
Series:	Data in Brief
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352340919311059

Similar Items

Temporal Evolution of Serum Concentrations of High‐Sensitivity Cardiac Troponin During 1 Year After Acute Coronary Syndrome Admission
by: Victor J. van den Berg, et al.
Published: (2021-01-01)

Acute Coronary Syndrome Subphenotypes Based on Repeated Biomarker Measurements in Relation to Long‐Term Mortality Risk
by: Marie de Bakker, et al.
Published: (2024-01-01)

YKL-40 – A NEW DIAGNOSTIC BIOMARCER FOR BENIGN BREAST DISEASES AND BREAST CANCER
by: Vanya Uzunova, et al.
Published: (2010-07-01)

SYNTAX score II predicts long-term mortality in patients with one- or two-vessel disease.
by: Maxime M Vroegindewey, et al.
Published: (2018-01-01)

Integrative Bioinformatics Approaches for Identification of Drug Targets in Hypertension
by: Daiane Hemerich, et al.
Published: (2018-04-01)

IgM anti-malondialdehyde low density lipoprotein antibody levels indicate coronary heart disease and necrotic core characteristics in the Nordic Diltiazem (NORDIL) study and the Integrated Imaging and Biomarker Study 3 (IBIS-3)Research in Context
by: Victor J. van den Berg, et al.
Published: (2018-10-01)

Effects of dietary L-carnitine on growth performance, body composition and antioxidant status of beluga (Huso huso) and comparison with Biomar diet
by: M Mohseni; M Pourkazemi; R Kazemi; R Taati
Published: (2017-01-01)

A Comparison of nutritional value of Biomar diet and earthworm as feed on growth performance and survival of ornamental Oscar fish (Asteronotus ocellatus)
by: Y. Mohammad Pour; M. Shapoori; M.S. Sadeghi; Sh. Gholami
Published: (2019-01-01)

HFrEF subphenotypes based on 4210 repeatedly measured circulating proteins are driven by different biological mechanismsResearch in context
by: Teun B. Petersen, et al.
Published: (2023-07-01)

Sex-based differences in cardiovascular proteomic profiles and their associations with adverse outcomes in patients with chronic heart failure
by: Marie de Bakker, et al.
Published: (2023-05-01)

Incorporating structural abnormalities in equivalent dipole layer based ECG simulations
by: Machteld J Boonstra, et al.
Published: (2022-12-01)

Chronic kidney disease and risk of atrial fibrillation and heart failure in general population‐based cohorts: the BiomarCaRE project
by: Martin Rehm, et al.
Published: (2022-02-01)

Diabetes status-related differences in risk factors and mediators of heart failure in the general population: results from the MORGAM/BiomarCaRE consortium
by: Matti A. Vuori, et al.
Published: (2021-09-01)

Cannabinoid, melanocortin and opioid receptor expression on DRD1 and DRD2 subpopulations in rat striatum
by: Ralph J Oude-Ophuis, et al.
Published: (2014-03-01)

Anti-Oxidized LDL Antibodies and Coronary Artery Disease: A Systematic Review
by: Victor J. van den Berg, et al.
Published: (2019-10-01)

Association of circulating metabolites with risk of coronary heart disease in a European population. Results from the Biomarkers for Cardiovascular Risk Assessment in Europe (BiomarCaRE) Consortium
by: Cavus, E, et al.
Published: (2019)

Identifying plasma proteomic signatures from health to heart failure, across the ejection fraction spectrum
by: Karolina Andrzejczyk, et al.
Published: (2024-06-01)

Left ventricular remodelling and prognosis after discharge in new‐onset acute heart failure with reduced ejection fraction
by: Jan C. van denBerge, et al.
Published: (2021-08-01)

Prognostic value of temporal patterns of global longitudinal strain in patients with chronic heart failure
by: Sabrina Abou Kamar, et al.
Published: (2023-01-01)

Coronary calcium scoring as first-line test to detect and exclude coronary artery disease in patients presenting to the general practitioner with stable chest pain: protocol of the cluster-randomised CONCRETE trial
by: Rozemarijn Vliegenthart, et al.
Published: (2022-04-01)

Potential role of left atrial strain in estimation of left atrial pressure in patients with chronic heart failure
by: Yaar S. Aga, et al.
Published: (2023-08-01)

Comparing Non-invasive Inverse Electrocardiography With Invasive Endocardial and Epicardial Electroanatomical Mapping During Sinus Rhythm
by: Robert W. Roudijk, et al.
Published: (2021-10-01)

Big Data and Artificial Intelligence: Opportunities and Threats in Electrophysiology
by: Rutger R van de Leur, et al.
Published: (2020-11-01)

A Simple and Computationally Efficient Approach to Multifactor Dimensionality Reduction Analysis of Gene-Gene Interactions for Quantitative Traits.
by: Jiang Gui, et al.
Published: (2013-01-01)

Associations of the vasoactive peptides CT-proET-1 and MR-proADM with incident type 2 diabetes: results from the BiomarCaRE Consortium
by: Chaterina Sujana, et al.
Published: (2022-06-01)

Use of Pharmacogenetic Drugs by the Dutch Population
by: Mohammad A. Alshabeeb, et al.
Published: (2019-07-01)

Contribution of cystatin C- and creatinine-based definitions of chronic kidney disease to cardiovascular risk assessment in 20 population-based and 3 disease cohorts: the BiomarCaRE project
by: Dietrich Rothenbacher, et al.
Published: (2020-11-01)

Association of glycated hemoglobin A1c levels with cardiovascular outcomes in the general population: results from the BiomarCaRE (Biomarker for Cardiovascular Risk Assessment in Europe) consortium
by: Christoph Sinning, et al.
Published: (2021-11-01)

Prognostic Value of Serial Galectin‐3 Measurements in Patients With Acute Heart Failure
by: Laura C. van Vark, et al.
Published: (2017-12-01)

Common Variants Associated With OSMR Expression Contribute to Carotid Plaque Vulnerability, but Not to Cardiovascular Disease in Humans
by: Danielle van Keulen, et al.
Published: (2021-04-01)

Integrating telemedicine in routine heart failure management: Experiences of healthcare professionals – A qualitative study
by: Jorna van Eijk, et al.
Published: (2024-08-01)

Plasma concentrations of molecular lipid species predict long-term clinical outcome in coronary artery disease patients
by: Sharda Anroedh, et al.
Published: (2018-09-01)

Simplification of a registry-based algorithm for ejection fraction prediction in heart failure patients: Applicability in cardiology centres of the Netherlands.
by: Elisa Dal Canto, et al.
Published: (2024-01-01)

Sex‐specific cardiovascular protein levels and their link with clinical outcome in heart failure
by: Marie deBakker, et al.
Published: (2024-02-01)

Exploration of the relationship between general health-related problems and subclinical coronary artery disease: a cross-sectional study in a general population
by: Rozemarijn Vliegenthart, et al.
Published: (2024-10-01)

Temporal patterns of macrophage‐ and neutrophil‐related markers are associated with clinical outcome in heart failure patients
by: Dominika Klimczak‐Tomaniak, et al.
Published: (2020-06-01)

Heart Rate Recovery 10 Seconds After Cessation of Exercise Predicts Death
by: Yordi J. van de Vegte, et al.
Published: (2018-04-01)

Genetic study links components of the autonomous nervous system to heart-rate profile during exercise
by: Niek Verweij, et al.
Published: (2018-03-01)

Automatic Identification of Patients With Unexplained Left Ventricular Hypertrophy in Electronic Health Record Data to Improve Targeted Treatment and Family Screening
by: Arjan Sammani, et al.
Published: (2022-04-01)

Individualized Angiotensin‐Converting Enzyme (ACE)‐Inhibitor Therapy in Stable Coronary Artery Disease Based on Clinical and Pharmacogenetic Determinants: The PERindopril GENEtic (PERGENE) Risk Model
by: Rohit M. Oemrawsingh, et al.
Published: (2016-03-01)